{"hands_on_practices": [{"introduction": "A deep understanding of any metabolic pathway begins with its fundamental chemistry. This exercise utilizes isotopic labeling, a cornerstone technique in biochemistry, to track the journey of each carbon atom from pyruvate through the initial steps of the pyruvate dehydrogenase complex (PDC) reaction. By predicting the fate of a radiolabel, you will solidify your understanding of the irreversible oxidative decarboxylation at the heart of the PDC's function [@problem_id:2595865].", "problem": "A mitochondrial preparation is supplied with pyruvate in which the carboxyl carbon is radiolabeled, denoted as $\\left[1\\text{-}{}^{14}\\mathrm{C}\\right]$pyruvate. The preparation contains an active pyruvate dehydrogenase complex (PDC), which includes its three enzymes (pyruvate dehydrogenase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase), with thiamine pyrophosphate (TPP), lipoamide, flavin adenine dinucleotide (FAD), nicotinamide adenine dinucleotide ($\\mathrm{NAD}^{+}$), and coenzyme A (CoA) present in saturating amounts. Immediately after a single catalytic turnover of the pyruvate dehydrogenase complex (before any entry of acetyl groups into the tricarboxylic acid cycle), you collect and separate the two primary products of the pyruvate dehydrogenase reaction: carbon dioxide ($\\mathrm{CO}_{2}$) and acetyl-CoA. \n\nUsing only the following fundamental bases:\n- The structural definition of pyruvate as $\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-}$, with carbon numbering $C\\text{-}1$ (carboxyl carbon, $\\mathrm{COO}^{-}$), $C\\text{-}2$ (keto carbonyl), and $C\\text{-}3$ (methyl).\n- The general mechanism of thiamine pyrophosphate–dependent decarboxylation in which the thiazolium ylide adds to a substrate carbonyl and facilitates loss of the carboxyl group as $\\mathrm{CO}_{2}$.\n- The organization of the pyruvate dehydrogenase complex in which the $E1$ component (pyruvate dehydrogenase, TPP dependent) performs decarboxylation, the $E2$ component (dihydrolipoyl transacetylase) transfers the two-carbon fragment to lipoamide and then to CoA, and the $E3$ component (dihydrolipoyl dehydrogenase) reoxidizes lipoamide with $\\mathrm{NAD}^{+}$ as the terminal electron acceptor.\n\nPredict which product will carry the $\\;{}^{14}\\mathrm{C}\\;$ label after this single pass through the pyruvate dehydrogenase complex and justify your choice by mapping the fate of each pyruvate carbon through the $E1$ decarboxylation step and subsequent transfer to acetyl-CoA.\n\nChoose one option:\nA. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in $\\mathrm{CO}_{2}$; the acetyl-CoA is unlabeled. \nB. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the carbonyl carbon of acetyl-CoA. \nC. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the methyl carbon of acetyl-CoA. \nD. The $\\;{}^{14}\\mathrm{C}\\;$ label partitions between $\\mathrm{CO}_{2}$ and acetyl-CoA due to equilibration during the $E1$ step.", "solution": "First, the problem statement must be validated for scientific soundness and logical consistency.\n\n**Step 1: Extracted Givens**\n- Substrate: Pyruvate with the carboxyl carbon radiolabeled, $[1\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\n- System: A mitochondrial preparation containing an active pyruvate dehydrogenase complex (PDC), which includes pyruvate dehydrogenase ($E1$), dihydrolipoyl transacetylase ($E2$), and dihydrolipoyl dehydrogenase ($E3$).\n- Cofactors: Thiamine pyrophosphate (TPP), lipoamide, flavin adenine dinucleotide (FAD), nicotinamide adenine dinucleotide ($\\mathrm{NAD}^{+}$), and coenzyme A (CoA) are present in saturating amounts.\n- Experimental Condition: Analysis is performed after a single catalytic turnover, before the products enter the tricarboxylic acid cycle.\n- Products to be analyzed: Carbon dioxide ($\\mathrm{CO}_{2}$) and acetyl-CoA.\n- Required Basis for Solution: The solution must be justified using the structural definition of pyruvate ($\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-}$, $C\\text{-}1$ being the carboxyl carbon), the general mechanism of TPP-dependent decarboxylation, and the functional organization of the $E1$, $E2$, and $E3$ components of the PDC.\n\n**Step 2: Validation**\nThe problem is well-defined and scientifically grounded. It describes a standard biochemical experiment based on the established mechanism of the pyruvate dehydrogenase complex, a central enzyme in metabolism. All components, cofactors, substrates, and products are correctly identified. The constraints—a single turnover and saturating cofactor concentrations—are clear and serve to isolate the specific reaction in question. The problem is free of internal contradictions, ambiguity, and factual errors. It is a valid scientific question that can be answered rigorously from the provided first principles.\n\n**Step 3: Verdict**\nThe problem is valid. The solution will now be derived.\n\nThe overall chemical transformation catalyzed by the pyruvate dehydrogenase complex is the oxidative decarboxylation of pyruvate to acetyl-CoA and $\\mathrm{CO}_{2}$:\n$$ \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-} + \\mathrm{CoA}\\text{-}\\mathrm{SH} + \\mathrm{NAD}^{+} \\longrightarrow \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA} + \\mathrm{CO}_{2} + \\mathrm{NADH} + \\mathrm{H}^{+} $$\nThe problem specifies that the substrate is pyruvate labeled at its carboxyl carbon, $C\\text{-}1$. The structure is therefore:\n$$ \\mathrm{CH}_{3}(C\\text{-}3)\\text{-}\\mathrm{CO}(C\\text{-}2)\\text{-}{}^{14}\\mathrm{COO}^{-}(C\\text{-}1) $$\nTo determine the fate of the ${}^{14}\\mathrm{C}$ label, we must trace the path of each carbon atom through the reaction sequence as it occurs on the three enzymes of the complex.\n\n**Analysis of the Reaction Mechanism:**\n\n1.  **Reaction on Pyruvate Dehydrogenase ($E1$): Decarboxylation**\n    The first step of the catalytic cycle occurs on the $E1$ subunit and involves the cofactor thiamine pyrophosphate (TPP). The catalytically active form of TPP is a carbanion (ylide) which acts as a nucleophile. This TPP ylide attacks the electrophilic carbonyl carbon ($C\\text{-}2$) of pyruvate. This forms a temporary tetrahedral adduct.\n    Critically, the thiazolium ring of TPP acts as an \"electron sink,\" stabilizing the negative charge that develops upon the breaking of the $C\\text{-}1\\text{-}C\\text{-}2$ bond. This bond cleavage results in the release of the carboxyl group ($C\\text{-}1$) as carbon dioxide, $\\mathrm{CO}_{2}$. Since $C\\text{-}1$ is the labeled carbon, the released carbon dioxide molecule will be radioactive: ${}^{14}\\mathrm{CO}_{2}$.\n    $$ \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}{}^{14}\\mathrm{COO}^{-} \\xrightarrow{E1,\\ TPP} \\left[ \\text{_hydroxyethyl-TPP intermediate_} \\right] + {}^{14}\\mathrm{CO}_{2} $$\n    The remaining two-carbon fragment, derived from $C\\text{-}2$ and $C\\text{-}3$ of pyruvate, is now covalently attached to TPP as a hydroxyethyl group.\n\n2.  **Reaction on Dihydrolipoyl Transacetylase ($E2$): Acetyl Group Transfer**\n    The hydroxyethyl-TPP intermediate is passed to the $E2$ subunit. Here, the hydroxyethyl group is simultaneously oxidized to an acetyl group and transferred to the lipoamide cofactor of $E2$. This forms an acetyl-dihydrolipoamide intermediate.\n    $$ \\left[ \\text{_hydroxyethyl-TPP_} \\right] + \\text{Lipoamide}_{ox} \\longrightarrow \\text{TPP} + \\left[ \\text{_acetyl-dihydrolipoamide_} \\right] $$\n    The $E2$ enzyme then catalyzes the transfer of this acetyl group from the lipoamide arm to coenzyme A, forming the final product, acetyl-CoA.\n    $$ \\left[ \\text{_acetyl-dihydrolipoamide_} \\right] + \\mathrm{CoA}\\text{-}\\mathrm{SH} \\longrightarrow \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA} + \\text{Lipoamide}_{red} $$\n    The resulting acetyl-CoA molecule ($\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA}$) is formed from the original $C\\text{-}2$ and $C\\text{-}3$ of pyruvate. The methyl carbon of acetyl-CoA derives from $C\\text{-}3$ of pyruvate, and the carbonyl carbon derives from $C\\text{-}2$ of pyruvate. Since neither $C\\text{-}2$ nor $C\\text{-}3$ was labeled, the acetyl-CoA product is unlabeled.\n\n3.  **Reaction on Dihydrolipoyl Dehydrogenase ($E3$): Regeneration**\n    The $E3$ subunit reoxidizes the reduced lipoamide ($\\text{Lipoamide}_{red}$) using FAD and $\\mathrm{NAD}^{+}$, regenerating the complex for another catalytic cycle. This step does not involve the carbon skeleton derived from pyruvate and is irrelevant to the distribution of the ${}^{14}\\mathrm{C}$ label.\n\n**Conclusion of Derivation:**\nThe mechanism of the pyruvate dehydrogenase complex dictates that the $C\\text{-}1$ (carboxyl) carbon of pyruvate is irreversibly lost as $\\mathrm{CO}_{2}$ in the first step of the reaction. The remaining two carbons, $C\\text{-}2$ and $C\\text{-}3$, form the acetyl group of acetyl-CoA. Consequently, when using $[1\\text{-}{}^{14}\\mathrm{C}]$pyruvate, the radioactive label appears exclusively in the $\\mathrm{CO}_{2}$ product.\n\n**Evaluation of Provided Options:**\n\nA. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in $\\mathrm{CO}_{2}$; the acetyl-CoA is unlabeled.\nThis statement is a direct consequence of the established reaction mechanism. The decarboxylation of the $C\\text{-}1$ carbon is the initial and irreversible chemical event concerning the carbon skeleton.\nVerdict: **Correct**.\n\nB. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the carbonyl carbon of acetyl-CoA.\nThis is incorrect. The carbonyl carbon of acetyl-CoA is derived from the $C\\text{-}2$ keto carbon of pyruvate. For the label to appear here, the substrate would need to be $[2\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\nVerdict: **Incorrect**.\n\nC. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the methyl carbon of acetyl-CoA.\nThis is incorrect. The methyl carbon of acetyl-CoA is derived from the $C\\text{-}3$ methyl carbon of pyruvate. For the label to appear here, the substrate would need to be $[3\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\nVerdict: **Incorrect**.\n\nD. The $\\;{}^{14}\\mathrm{C}\\;$ label partitions between $\\mathrm{CO}_{2}$ and acetyl-CoA due to equilibration during the $E1$ step.\nThis is mechanistically baseless. The enzymatic reaction is stereospecific and proceeds through a defined sequence of covalent intermediates. There is no plausible mechanism for an equilibration or \"scrambling\" of the carboxyl carbon with the other two carbons of the pyruvate backbone. The decarboxylation is a committed and irreversible step.\nVerdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2595865"}, {"introduction": "The efficiency of the PDC is not just due to its individual enzymes, but its nature as an integrated complex where intermediates are passed directly from one active site to the next. This phenomenon, known as substrate channeling, hinges on the precise structural organization and binding kinetics between subunits. This practice provides a quantitative look into this process, asking you to model how the affinity between the E1 and E2 components dictates the effective rate of intermediate transfer, highlighting a key kinetic advantage of multi-enzyme complexes [@problem_id:2595830].", "problem": "In the Pyruvate Dehydrogenase Complex (PDC), the E1 component (pyruvate dehydrogenase) generates a covalent hydroxyethyl intermediate on Thiamine Pyrophosphate (TPP), which is transferred to the oxidized lipoyl-lysine arm of E2 (dihydrolipoyl transacetylase). Consider a minimal kinetic scheme in which E1 and E2 associate and dissociate with second-order association rate constant $k_{\\mathrm{on}}$ and first-order dissociation rate constant $k_{\\mathrm{off}}$, respectively. When E1 and E2 are bound, the chemical step of intermediate transfer proceeds with first-order rate constant $k_{t}$. When E1 and E2 are not bound, the intermediate on E1 does not transfer and instead is lost to side reactions with first-order rate constant $k_{d}$. Assume that binding/unbinding between E1 and E2 reaches a rapid pre-equilibrium relative to both the chemical transfer step and the side-reaction loss, so that the fraction of time in the bound state is determined by the binding equilibrium. Also assume that the structural organization of the complex creates a local effective concentration of E2 around E1 equal to $[\\mathrm{E2}]_{\\mathrm{eff}}$.\n\nYou are given the following baseline parameter values for the wild type:\n- $k_{\\mathrm{on}} = 1.0 \\times 10^{7}\\,\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$,\n- $k_{\\mathrm{off}}^{\\mathrm{WT}} = 10\\,\\mathrm{s}^{-1}$,\n- $k_{t} = 200\\,\\mathrm{s}^{-1}$,\n- $k_{d} = 20\\,\\mathrm{s}^{-1}$,\n- $[\\mathrm{E2}]_{\\mathrm{eff}} = 0.50\\,\\mathrm{mM}$.\n\nA mutation specifically disrupts E1-E2 binding by increasing $k_{\\mathrm{off}}$ $50$-fold (to $k_{\\mathrm{off}}^{\\mathrm{mut}} = 500\\,\\mathrm{s}^{-1}$), without changing $k_{\\mathrm{on}}$, $k_{t}$, $k_{d}$, or $[\\mathrm{E2}]_{\\mathrm{eff}}$. Define the effective first-order rate constant for intermediate transfer, $k_{\\mathrm{eff}}$, as the coefficient that multiplies the intermediate concentration in the net loss term due to successful transfer from E1 to E2 under the rapid pre-equilibrium assumption.\n\nWhich option best predicts how $k_{\\mathrm{eff}}$ changes as a result of the mutation?\n\nA. $k_{\\mathrm{eff}}$ decreases by about $9\\%$, from approximately $200\\,\\mathrm{s}^{-1}$ to approximately $182\\,\\mathrm{s}^{-1}$, because the reduced bound-state occupancy lowers the frequency of productive transfer events even though $k_{t}$ is unchanged.\n\nB. $k_{\\mathrm{eff}}$ remains approximately $200\\,\\mathrm{s}^{-1}$, because $k_{t}$ is unchanged and thus transfer chemistry is unaffected.\n\nC. $k_{\\mathrm{eff}}$ decreases by a factor of $50$, to approximately $4\\,\\mathrm{s}^{-1}$, because the $50$-fold higher $k_{\\mathrm{off}}$ directly slows the transfer step by the same factor.\n\nD. $k_{\\mathrm{eff}}$ increases to approximately $220\\,\\mathrm{s}^{-1}$, because faster dissociation increases the turnover of E1 and E2, improving overall transfer frequency.", "solution": "The problem statement will first be subjected to rigorous validation.\n\n### Step 1: Extract Givens\nThe explicit parameters and assumptions provided in the problem statement are:\n- The system involves the Pyruvate Dehydrogenase Complex (PDC), specifically components E1 and E2.\n- A kinetic scheme is proposed:\n    1. E1 and E2 associate and dissociate: $\\text{E1} + \\text{E2} \\rightleftharpoons \\text{E1} \\cdot \\text{E2}$\n    2. Association rate constant: $k_{\\mathrm{on}} = 1.0 \\times 10^{7}\\,\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$\n    3. Wild-type dissociation rate constant: $k_{\\mathrm{off}}^{\\mathrm{WT}} = 10\\,\\mathrm{s}^{-1}$\n    4. Intermediate transfer rate constant (when bound): $k_{t} = 200\\,\\mathrm{s}^{-1}$\n    5. Side reaction rate constant (when unbound): $k_{d} = 20\\,\\mathrm{s}^{-1}$\n- Assumption 1: Binding/unbinding between E1 and E2 reaches a rapid pre-equilibrium relative to the chemical steps ($k_{t}$ and $k_{d}$).\n- Assumption 2: The structural organization creates a local effective concentration of E2 around E1: $[\\mathrm{E2}]_{\\mathrm{eff}} = 0.50\\,\\mathrm{mM}$.\n- A mutation is introduced that specifically affects binding.\n- Mutant dissociation rate constant: $k_{\\mathrm{off}}^{\\mathrm{mut}} = 50 \\times k_{\\mathrm{off}}^{\\mathrm{WT}} = 50 \\times 10\\,\\mathrm{s}^{-1} = 500\\,\\mathrm{s}^{-1}$.\n- The parameters $k_{\\mathrm{on}}$, $k_{t}$, $k_{d}$, and $[\\mathrm{E2}]_{\\mathrm{eff}}$ are unchanged by the mutation.\n- Definition: The effective first-order rate constant for intermediate transfer, $k_{\\mathrm{eff}}$, is the coefficient that multiplies the total intermediate concentration in the net loss term due to successful transfer from E1 to E2.\n\n### Step 2: Validate Using Extracted Givens\nThe problem describes a kinetic model of protein-protein interaction and subsequent substrate transfer within a well-known multi-enzyme complex.\n- **Scientifically Grounded:** The model is based on standard principles of chemical kinetics and enzyme mechanisms. The concepts of association/dissociation, effective concentration due to scaffolding, and rapid pre-equilibrium are pillars of modern biochemistry and biophysics. The PDC is a classic example of such organization. The problem is scientifically sound.\n- **Well-Posed:** The problem provides all necessary parameters and a clear definition of the quantity to be calculated ($k_{\\mathrm{eff}}$). The rapid pre-equilibrium assumption simplifies the kinetics to an algebraic problem, guaranteeing a unique, stable solution. The parameters given ($k_{on}, k_{off}, k_t, k_d$) are consistent with the \"rapid pre-equilibrium\" assumption, as the rates governing binding equilibrium are generally faster than the rates of the chemical steps. For the wild-type, the pseudo-first-order rate of association is $k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}} = (1.0 \\times 10^{7}\\,\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1})(0.50 \\times 10^{-3}\\,\\mathrm{M}) = 5000\\,\\mathrm{s}^{-1}$. Both this rate and $k_{\\mathrm{off}}^{\\mathrm{WT}} = 10\\,\\mathrm{s}^{-1}$ are significantly different from and generally faster than $k_t = 200\\,\\mathrm{s}^{-1}$ and $k_d = 20\\,\\mathrm{s}^{-1}$, justifying the assumption.\n- **Objective:** The language is precise and quantitative, free of subjective or ambiguous terminology.\n\n### Step 3: Verdict and Action\nThe problem is scientifically valid, well-posed, and objective. It is free of the flaws listed in the instructions. A rigorous solution can and must be derived.\n\n### Derivation of the Solution\n\nThe kinetic scheme for the E1 intermediate (let us denote it E1-Int) is as follows:\n$$ \\text{E1-Int} + \\text{E2} \\underset{k_{\\mathrm{off}}}{\\stackrel{k_{\\mathrm{on}}}{\\rightleftharpoons}} \\text{E1-Int} \\cdot \\text{E2} $$\nThe bound complex, $\\text{E1-Int} \\cdot \\text{E2}$, undergoes productive transfer with rate constant $k_{t}$:\n$$ \\text{E1-Int} \\cdot \\text{E2} \\xrightarrow{k_{t}} \\text{Products} $$\nThe free intermediate, $\\text{E1-Int}$, is lost to a side reaction with rate constant $k_{d}$:\n$$ \\text{E1-Int} \\xrightarrow{k_{d}} \\text{Side Products} $$\nThe problem defines the rate of productive transfer as $v_t = k_{\\mathrm{eff}} [\\text{E1-Int}]_{\\text{total}}$. We also know that the transfer step only occurs from the bound state: $v_t = k_t [\\text{E1-Int} \\cdot \\text{E2}]$.\nEquating these gives: $k_{\\mathrm{eff}} [\\text{E1-Int}]_{\\text{total}} = k_t [\\text{E1-Int} \\cdot \\text{E2}]$.\nFrom this, we find that $k_{\\mathrm{eff}}$ is $k_{t}$ modulated by the fraction of the intermediate in the bound state, $f_{\\text{bound}}$:\n$$ k_{\\mathrm{eff}} = k_{t} \\frac{[\\text{E1-Int} \\cdot \\text{E2}]}{[\\text{E1-Int}]_{\\text{total}}} = k_{t} f_{\\text{bound}} $$\nThe rapid pre-equilibrium assumption means that the binding reaction is always at equilibrium. The dissociation constant is $K_D = \\frac{k_{\\mathrm{off}}}{k_{\\mathrm{on}}}$. The equilibrium is described by:\n$$ K_D = \\frac{[\\text{E1-Int}]_{\\text{free}} [\\text{E2}]}{[\\text{E1-Int} \\cdot \\text{E2}]} $$\nThe fraction bound, $f_{\\text{bound}}$, is given by:\n$$ f_{\\text{bound}} = \\frac{[\\text{E1-Int} \\cdot \\text{E2}]}{[\\text{E1-Int}]_{\\text{free}} + [\\text{E1-Int} \\cdot \\text{E2}]} $$\nBy rearranging the equilibrium expression to $[\\text{E1-Int}]_{\\text{free}} = K_D \\frac{[\\text{E1-Int} \\cdot \\text{E2}]}{[\\text{E2}]}$ and substituting into the equation for $f_{\\text{bound}}$:\n$$ f_{\\text{bound}} = \\frac{[\\text{E1-Int} \\cdot \\text{E2}]}{K_D \\frac{[\\text{E1-Int} \\cdot \\text{E2}]}{[\\text{E2}]} + [\\text{E1-Int} \\cdot \\text{E2}]} = \\frac{1}{\\frac{K_D}{[\\text{E2}]} + 1} = \\frac{[\\text{E2}]}{K_D + [\\text{E2}]} $$\nUsing the effective concentration $[\\mathrm{E2}]_{\\mathrm{eff}}$ and substituting $K_D = k_{\\mathrm{off}}/k_{\\mathrm{on}}$, we obtain the final expression for $k_{\\mathrm{eff}}$:\n$$ k_{\\mathrm{eff}} = k_{t} \\left( \\frac{[\\mathrm{E2}]_{\\mathrm{eff}}}{\\frac{k_{\\mathrm{off}}}{k_{\\mathrm{on}}} + [\\mathrm{E2}]_{\\mathrm{eff}}} \\right) = k_{t} \\left( \\frac{k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}}{k_{\\mathrm{off}} + k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}} \\right) $$\n\n### Calculation for Wild Type (WT)\nFirst, convert $[\\mathrm{E2}]_{\\mathrm{eff}}$ to Molar: $[\\mathrm{E2}]_{\\mathrm{eff}} = 0.50\\,\\mathrm{mM} = 0.50 \\times 10^{-3}\\,\\mathrm{M}$.\nThe term $k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}$ represents the pseudo-first-order rate constant for association:\n$$ k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}} = (1.0 \\times 10^{7}\\,\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1})(0.50 \\times 10^{-3}\\,\\mathrm{M}) = 5000\\,\\mathrm{s}^{-1} $$\nNow, calculate $k_{\\mathrm{eff}}^{\\mathrm{WT}}$ using $k_{\\mathrm{off}}^{\\mathrm{WT}} = 10\\,\\mathrm{s}^{-1}$:\n$$ k_{\\mathrm{eff}}^{\\mathrm{WT}} = k_{t} \\left( \\frac{5000\\,\\mathrm{s}^{-1}}{10\\,\\mathrm{s}^{-1} + 5000\\,\\mathrm{s}^{-1}} \\right) = 200\\,\\mathrm{s}^{-1} \\left( \\frac{5000}{5010} \\right) = 200\\,\\mathrm{s}^{-1} \\left( \\frac{500}{501} \\right) \\approx 199.60\\,\\mathrm{s}^{-1} $$\nThis value is approximately $200\\,\\mathrm{s}^{-1}$.\n\n### Calculation for Mutant (mut)\nThe mutation increases $k_{\\mathrm{off}}$ to $k_{\\mathrm{off}}^{\\mathrm{mut}} = 500\\,\\mathrm{s}^{-1}$. All other parameters remain constant.\n$$ k_{\\mathrm{eff}}^{\\mathrm{mut}} = k_{t} \\left( \\frac{k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}}{k_{\\mathrm{off}}^{\\mathrm{mut}} + k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}} \\right) = 200\\,\\mathrm{s}^{-1} \\left( \\frac{5000\\,\\mathrm{s}^{-1}}{500\\,\\mathrm{s}^{-1} + 5000\\,\\mathrm{s}^{-1}} \\right) $$\n$$ k_{\\mathrm{eff}}^{\\mathrm{mut}} = 200\\,\\mathrm{s}^{-1} \\left( \\frac{5000}{5500} \\right) = 200\\,\\mathrm{s}^{-1} \\left( \\frac{10}{11} \\right) \\approx 181.82\\,\\mathrm{s}^{-1} $$\nThis value is approximately $182\\,\\mathrm{s}^{-1}$.\n\nThe percentage decrease is:\n$$ \\text{Decrease} = \\frac{k_{\\mathrm{eff}}^{\\mathrm{WT}} - k_{\\mathrm{eff}}^{\\mathrm{mut}}}{k_{\\mathrm{eff}}^{\\mathrm{WT}}} \\times 100\\% = \\frac{199.60 - 181.82}{199.60} \\times 100\\% = \\frac{17.78}{199.60} \\times 100\\% \\approx 8.9\\% $$\n\n### Evaluation of Options\n\nA. $k_{\\mathrm{eff}}$ decreases by about $9\\%$, from approximately $200\\,\\mathrm{s}^{-1}$ to approximately $182\\,\\mathrm{s}^{-1}$, because the reduced bound-state occupancy lowers the frequency of productive transfer events even though $k_{t}$ is unchanged.\n- Our calculation shows $k_{\\mathrm{eff}}^{\\mathrm{WT}} \\approx 200\\,\\mathrm{s}^{-1}$ and $k_{\\mathrm{eff}}^{\\mathrm{mut}} \\approx 182\\,\\mathrm{s}^{-1}$.\n- The calculated decrease is approximately $8.9\\%$, which is about $9\\%$.\n- The reasoning is correct. The mutation increases $k_{\\mathrm{off}}$, which weakens binding (increases $K_D$). This reduces the fraction of time the complex is in the bound state ($f_{\\text{bound}}$ decreases from $500/501 \\approx 0.998$ to $10/11 \\approx 0.909$). Since $k_{\\mathrm{eff}} = k_{t} f_{\\text{bound}}$, a lower $f_{\\text{bound}}$ results in a lower $k_{\\mathrm{eff}}$.\nVerdict: **Correct**.\n\nB. $k_{\\mathrm{eff}}$ remains approximately $200\\,\\mathrm{s}^{-1}$, because $k_{t}$ is unchanged and thus transfer chemistry is unaffected.\n- This is incorrect. The effective rate constant $k_{\\mathrm{eff}}$ is not identical to the intrinsic chemical rate constant $k_{t}$. It is a composite constant that depends on both the intrinsic chemistry ($k_{t}$) and the binding equilibrium ($K_D$). The mutation perturbs the equilibrium, which in turn alters $k_{\\mathrm{eff}}$.\nVerdict: **Incorrect**.\n\nC. $k_{\\mathrm{eff}}$ decreases by a factor of $50$, to approximately $4\\,\\mathrm{s}^{-1}$, because the $50$-fold higher $k_{\\mathrm{off}}$ directly slows the transfer step by the same factor.\n- This is incorrect. The relationship between $k_{\\mathrm{eff}}$ and $k_{\\mathrm{off}}$ is not simple inverse proportionality. The calculation shows a decrease to $\\approx 182\\,\\mathrm{s}^{-1}$, not $4\\,\\mathrm{s}^{-1}$ (which would be $\\approx 200/50$). This fallacious reasoning would only apply in the limit where $k_{\\mathrm{off}} \\gg k_{\\mathrm{on}}[\\mathrm{E2}]_{\\mathrm{eff}}$, which is not the case here ($500\\,\\mathrm{s}^{-1}$ is not much greater than $5000\\,\\mathrm{s}^{-1}$).\nVerdict: **Incorrect**.\n\nD. $k_{\\mathrm{eff}}$ increases to approximately $220\\,\\mathrm{s}^{-1}$, because faster dissociation increases the turnover of E1 and E2, improving overall transfer frequency.\n- This is incorrect. The calculation clearly shows a decrease in $k_{\\mathrm{eff}}$. The reasoning is flawed. Increased $k_{\\mathrm{off}}$ means the productive $\\text{E1-Int} \\cdot \\text{E2}$ complex is less stable and dissociates more readily. This reduces the probability that the transfer reaction (with rate $k_{t}$) occurs before dissociation, thereby lowering the effective rate of transfer. The concept of turnover is misapplied to this specific step.\nVerdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2595830"}, {"introduction": "Beyond its intrinsic kinetics, the activity of the PDC is exquisitely tuned to the metabolic state of the cell. This regulation is achieved through a sophisticated system of covalent modification, governed by the opposing activities of a kinase (PDK) and a phosphatase (PDP). This final exercise challenges you to build a quantitative model of this regulatory circuit, integrating multiple allosteric signals—such as the levels of $\\mathrm{NADH}$, acetyl-CoA, and $\\mathrm{Ca}^{2+}$—to determine the steady-state activity of the complex, bridging molecular mechanism with cellular physiology [@problem_id:2595862].", "problem": "A mitochondrially localized Pyruvate Dehydrogenase Complex (PDC) toggles between a catalytically active, dephosphorylated state and an inactive, phosphorylated state. The interconversion is governed by Pyruvate Dehydrogenase Kinase (PDK), which phosphorylates the E1 subunit and inactivates PDC, and Pyruvate Dehydrogenase Phosphatase (PDP), which dephosphorylates and activates PDC. Assume a two-state model in which the fraction of active PDC is $a(t)$ and the fraction of inactive PDC is $i(t)$, with $a(t)+i(t)=1$. Assume pseudo-first-order kinetics for the interconversion, with an effective inactivation rate $v_{PDK}$ and an effective reactivation rate $v_{PDP}$, each depending on regulators through saturating factors.\n\nYou are given the following regulator-dependent forms for the effective rate coefficients:\n$$\nv_{PDK} \\;=\\; k_{PDK}^{0}\\,\\underbrace{\\left(1+\\alpha_{NADH}\\,\\frac{[\\mathrm{NADH}]}{K_{a,NADH}+[\\mathrm{NADH}]}\\right)}_{\\text{activation by NADH}}\\,\\underbrace{\\left(1+\\alpha_{AcCoA}\\,\\frac{[\\mathrm{AcCoA}]}{K_{a,AcCoA}+[\\mathrm{AcCoA}]}\\right)}_{\\text{activation by AcCoA}}\\,\\underbrace{\\frac{1}{1+\\left(\\frac{[\\mathrm{Pyruvate}]}{K_{i,Pyr}}\\right)^{h_{Pyr}}}}_{\\text{inhibition by pyruvate}}\\,\\underbrace{\\frac{1}{1+\\frac{[\\mathrm{ADP}]}{K_{i,ADP}}}}_{\\text{inhibition by ADP}},\n$$\n$$\nv_{PDP} \\;=\\; k_{PDP}^{0}\\,\\underbrace{\\left(1+\\beta_{Ca}\\,\\frac{[\\mathrm{Ca}^{2+}]}{K_{a,Ca}+[\\mathrm{Ca}^{2+}]}\\right)}_{\\text{activation by Ca}^{2+}}.\n$$\n\nHere $k_{PDK}^{0}$ and $k_{PDP}^{0}$ are baseline first-order rate constants. Nicotinamide Adenine Dinucleotide (reduced form, NADH), Acetyl-Coenzyme A (AcCoA), pyruvate, and Adenosine Diphosphate (ADP) regulate PDK as noted. Calcium ions $\\mathrm{Ca}^{2+}$ activate PDP, reflecting coupling of PDC activation to excitation-contraction in tissues such as heart and skeletal muscle.\n\nTask:\n1) Starting from conservation of total PDC and mass-action interconversion between the two states, derive an expression for the steady-state active fraction $f_{active}$ in terms of $v_{PDK}$ and $v_{PDP}$.\n\n2) Using your derived expression, compute $f_{active}$ for the following mitochondrial conditions and parameters:\n- $k_{PDK}^{0}=0.08\\ \\mathrm{s}^{-1}$, $k_{PDP}^{0}=0.06\\ \\mathrm{s}^{-1}$.\n- $[\\mathrm{NADH}]=0.3\\ \\mathrm{mM}$, $K_{a,NADH}=0.1\\ \\mathrm{mM}$, $\\alpha_{NADH}=3$.\n- $[\\mathrm{AcCoA}]=0.10\\ \\mathrm{mM}$, $K_{a,AcCoA}=0.05\\ \\mathrm{mM}$, $\\alpha_{AcCoA}=2$.\n- $[\\mathrm{Pyruvate}]=0.50\\ \\mathrm{mM}$, $K_{i,Pyr}=0.20\\ \\mathrm{mM}$, $h_{Pyr}=2$.\n- $[\\mathrm{ADP}]=0.50\\ \\mathrm{mM}$, $K_{i,ADP}=0.20\\ \\mathrm{mM}$.\n- $[\\mathrm{Ca}^{2+}]=0.80\\ \\mu\\mathrm{M}$, $K_{a,Ca}=0.30\\ \\mu\\mathrm{M}$, $\\beta_{Ca}=5$.\n\nReport the final value of $f_{active}$ as a unitless decimal, rounded to four significant figures.", "solution": "We begin from a two-state interconversion model that treats the active, dephosphorylated PDC as one state and the inactive, phosphorylated PDC as another. Let $a(t)$ denote the fraction of total PDC in the active state and $i(t)$ the fraction in the inactive state. Conservation of the total enzyme implies $a(t)+i(t)=1$ for all $t$.\n\nAssume pseudo-first-order kinetics for the interconversion with effective rate coefficients $v_{PDK}$ for active $\\to$ inactive (phosphorylation by Pyruvate Dehydrogenase Kinase) and $v_{PDP}$ for inactive $\\to$ active (dephosphorylation by Pyruvate Dehydrogenase Phosphatase). Then the time evolution of $a(t)$ is given by the net influx from the inactive state minus the efflux to the inactive state:\n$$\n\\frac{da}{dt} \\;=\\; v_{PDP}\\,i(t)\\;-\\;v_{PDK}\\,a(t).\n$$\nUsing $i(t)=1-a(t)$ from conservation,\n$$\n\\frac{da}{dt} \\;=\\; v_{PDP}\\,(1-a)\\;-\\;v_{PDK}\\,a \\;=\\; v_{PDP} - (v_{PDK}+v_{PDP})\\,a.\n$$\nAt steady state, $\\frac{da}{dt}=0$, so\n$$\n0 \\;=\\; v_{PDP} - (v_{PDK}+v_{PDP})\\,a_{\\ast},\n$$\nwhich yields\n$$\na_{\\ast} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}}.\n$$\nThus the steady-state active fraction is\n$$\nf_{active} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}}.\n$$\n\nNext, we compute $v_{PDK}$ and $v_{PDP}$ from the given regulator-dependent forms and parameter values.\n\nCompute each regulatory factor for $v_{PDK}$:\n- Activation by Nicotinamide Adenine Dinucleotide (reduced form, NADH):\n$$\n1+\\alpha_{NADH}\\,\\frac{[\\mathrm{NADH}]}{K_{a,NADH}+[\\mathrm{NADH}]} \\;=\\; 1 + 3\\,\\frac{0.3}{0.1+0.3} \\;=\\; 1 + 3\\,\\frac{0.3}{0.4} \\;=\\; 1 + 3\\cdot 0.75 \\;=\\; 3.25.\n$$\n- Activation by Acetyl-Coenzyme A (AcCoA):\n$$\n1+\\alpha_{AcCoA}\\,\\frac{[\\mathrm{AcCoA}]}{K_{a,AcCoA}+[\\mathrm{AcCoA}]} \\;=\\; 1 + 2\\,\\frac{0.10}{0.05+0.10} \\;=\\; 1 + 2\\,\\frac{0.10}{0.15} \\;=\\; 1 + 2\\cdot\\frac{2}{3} \\;=\\; \\frac{7}{3}\\;\\approx\\;2.333\\ldots\n$$\n- Inhibition by pyruvate with Hill coefficient $h_{Pyr}=2$:\n$$\n\\frac{1}{1+\\left(\\frac{[\\mathrm{Pyruvate}]}{K_{i,Pyr}}\\right)^{h_{Pyr}}} \\;=\\; \\frac{1}{1+\\left(\\frac{0.50}{0.20}\\right)^{2}} \\;=\\; \\frac{1}{1+(2.5)^{2}} \\;=\\; \\frac{1}{1+6.25} \\;=\\; \\frac{1}{7.25} \\;=\\; \\frac{4}{29}.\n$$\n- Inhibition by Adenosine Diphosphate (ADP):\n$$\n\\frac{1}{1+\\frac{[\\mathrm{ADP}]}{K_{i,ADP}}} \\;=\\; \\frac{1}{1+\\frac{0.50}{0.20}} \\;=\\; \\frac{1}{1+2.5} \\;=\\; \\frac{1}{3.5} \\;=\\; \\frac{2}{7}.\n$$\n\nMultiply these factors to get the net modulation of $k_{PDK}^{0}$:\n$$\n\\left(3.25\\right)\\left(\\frac{7}{3}\\right)\\left(\\frac{4}{29}\\right)\\left(\\frac{2}{7}\\right)\n\\;=\\; \\frac{13}{4}\\cdot\\frac{7}{3}\\cdot\\frac{4}{29}\\cdot\\frac{2}{7}\n\\;=\\; \\frac{91}{12}\\cdot\\frac{4}{29}\\cdot\\frac{2}{7}\n\\;=\\; \\frac{26}{87}.\n$$\nTherefore,\n$$\nv_{PDK} \\;=\\; k_{PDK}^{0}\\cdot \\frac{26}{87} \\;=\\; 0.08\\ \\mathrm{s}^{-1}\\cdot \\frac{26}{87} \\;=\\; \\frac{2.08}{87}\\ \\mathrm{s}^{-1} \\;\\approx\\; 0.023908\\ \\mathrm{s}^{-1}.\n$$\n\nNow compute $v_{PDP}$:\n- Activation by calcium:\n$$\n1+\\beta_{Ca}\\,\\frac{[\\mathrm{Ca}^{2+}]}{K_{a,Ca}+[\\mathrm{Ca}^{2+}]} \\;=\\; 1 + 5\\,\\frac{0.80}{0.30+0.80} \\;=\\; 1 + 5\\,\\frac{0.80}{1.10} \\;=\\; 1 + 5\\cdot\\frac{8}{11} \\;=\\; 1 + \\frac{40}{11} \\;=\\; \\frac{51}{11}.\n$$\nTherefore,\n$$\nv_{PDP} \\;=\\; k_{PDP}^{0}\\cdot \\frac{51}{11} \\;=\\; 0.06\\ \\mathrm{s}^{-1}\\cdot \\frac{51}{11} \\;=\\; \\frac{3.06}{11}\\ \\mathrm{s}^{-1} \\;\\approx\\; 0.278182\\ \\mathrm{s}^{-1}.\n$$\n\nFinally, the steady-state active fraction is\n$$\nf_{active} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}} \\;=\\; \\frac{\\frac{3.06}{11}}{\\frac{3.06}{11}+\\frac{2.08}{87}} \\;=\\; \\frac{13311}{14455} \\;\\approx\\; 0.9208936.\n$$\n\nRounded to four significant figures as a unitless decimal:\n$$\nf_{active} \\;\\approx\\; 0.9209.\n$$", "answer": "$$\\boxed{0.9209}$$", "id": "2595862"}]}